Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1742 | 6517 | 40.7 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BONE MINERAL DENSITY | authKW | 233471 | 10% | 8% | 632 |
2 | OSTEOPOROSIS | authKW | 214826 | 14% | 5% | 943 |
3 | OSTEOCALCIN | authKW | 173892 | 4% | 15% | 255 |
4 | OSTEOBLAST | authKW | 107633 | 7% | 5% | 436 |
5 | BONE | journal | 89604 | 5% | 5% | 357 |
6 | ENDOCRINOLOGY & METABOLISM | WoSSC | 75516 | 42% | 1% | 2705 |
7 | OSTEOPOROSIS INTERNATIONAL | journal | 74487 | 4% | 6% | 280 |
8 | JOURNAL OF BONE AND MINERAL RESEARCH | journal | 61489 | 5% | 4% | 296 |
9 | SIMVASTATIN | authKW | 52836 | 2% | 7% | 154 |
10 | MARROW FAT | authKW | 50615 | 0% | 54% | 20 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 75516 | 42% | 1% | 2705 |
2 | Dentistry, Oral Surgery & Medicine | 2047 | 5% | 0% | 323 |
3 | Orthopedics | 1934 | 5% | 0% | 341 |
4 | Geriatrics & Gerontology | 1440 | 3% | 0% | 182 |
5 | Nutrition & Dietetics | 1306 | 4% | 0% | 283 |
6 | Medicine, Research & Experimental | 1138 | 6% | 0% | 396 |
7 | Cell Biology | 1015 | 8% | 0% | 547 |
8 | Cell & Tissue Engineering | 437 | 1% | 0% | 55 |
9 | Rheumatology | 410 | 2% | 0% | 114 |
10 | Medicine, General & Internal | 377 | 5% | 0% | 344 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LIPID CHEM MOL BIOL | 23488 | 0% | 31% | 16 |
2 | AGING BONE PROGRAM | 17647 | 0% | 54% | 7 |
3 | ENHANCING FOODS PROTECT HLTH | 17647 | 0% | 54% | 7 |
4 | UNDER ORAL SCI | 14051 | 0% | 100% | 3 |
5 | SPINAL DIS UNIT | 12487 | 0% | 67% | 4 |
6 | LIOMM | 11704 | 0% | 50% | 5 |
7 | AGEING BONE PROGRAM | 11091 | 0% | 30% | 8 |
8 | PAOLO SOTGIU QUANTITAT EVOLUTIONARY PSYCHI | 10702 | 0% | 57% | 4 |
9 | E0366 | 10639 | 0% | 45% | 5 |
10 | AUGUSTA VET ADM MED | 10537 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BONE | 89604 | 5% | 5% | 357 |
2 | OSTEOPOROSIS INTERNATIONAL | 74487 | 4% | 6% | 280 |
3 | JOURNAL OF BONE AND MINERAL RESEARCH | 61489 | 5% | 4% | 296 |
4 | CALCIFIED TISSUE INTERNATIONAL | 42576 | 3% | 4% | 210 |
5 | JOURNAL OF BONE AND MINERAL METABOLISM | 24627 | 1% | 6% | 87 |
6 | CURRENT OSTEOPOROSIS REPORTS | 9212 | 0% | 9% | 22 |
7 | JOURNAL OF CLINICAL DENSITOMETRY | 5961 | 1% | 3% | 37 |
8 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 5383 | 3% | 1% | 169 |
9 | BONE AND MINERAL | 3797 | 0% | 3% | 24 |
10 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 3519 | 1% | 2% | 49 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BONE MINERAL DENSITY | 233471 | 10% | 8% | 632 | Search BONE+MINERAL+DENSITY | Search BONE+MINERAL+DENSITY |
2 | OSTEOPOROSIS | 214826 | 14% | 5% | 943 | Search OSTEOPOROSIS | Search OSTEOPOROSIS |
3 | OSTEOCALCIN | 173892 | 4% | 15% | 255 | Search OSTEOCALCIN | Search OSTEOCALCIN |
4 | OSTEOBLAST | 107633 | 7% | 5% | 436 | Search OSTEOBLAST | Search OSTEOBLAST |
5 | BONE | 61028 | 6% | 4% | 368 | Search BONE | Search BONE |
6 | SIMVASTATIN | 52836 | 2% | 7% | 154 | Search SIMVASTATIN | Search SIMVASTATIN |
7 | MARROW FAT | 50615 | 0% | 54% | 20 | Search MARROW+FAT | Search MARROW+FAT |
8 | BONE METABOLISM | 45558 | 2% | 10% | 100 | Search BONE+METABOLISM | Search BONE+METABOLISM |
9 | BONE TURNOVER | 38867 | 2% | 9% | 98 | Search BONE+TURNOVER | Search BONE+TURNOVER |
10 | BONE MARROW FAT | 36023 | 0% | 77% | 10 | Search BONE+MARROW+FAT | Search BONE+MARROW+FAT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MEIER, C , SCHWARTZ, AV , EGGER, A , LECKA-CZERNIK, B , (2016) EFFECTS OF DIABETES DRUGS ON THE SKELETON.BONE. VOL. 82. ISSUE . P. 93 -100 | 81 | 70% | 18 |
2 | FERRON, M , LACOMBE, J , (2014) REGULATION OF ENERGY METABOLISM BY THE SKELETON: OSTEOCALCIN AND BEYOND.ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. VOL. 561. ISSUE . P. 137 -146 | 125 | 73% | 27 |
3 | MCCABE, LR , ZHANG, J , RAEHTZ, S , (2011) UNDERSTANDING THE SKELETAL PATHOLOGY OF TYPE 1 AND 2 DIABETES MELLITUS.CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION. VOL. 21. ISSUE 2. P. 187 -206 | 150 | 70% | 22 |
4 | PALERMO, A , D'ONOFRIO, L , EASTELL, R , SCHWARTZ, AV , POZZILLI, P , NAPOLI, N , (2015) ORAL ANTI-DIABETIC DRUGS AND FRACTURE RISK, CUT TO THE BONE: SAFE OR DANGEROUS? A NARRATIVE REVIEW.OSTEOPOROSIS INTERNATIONAL. VOL. 26. ISSUE 8. P. 2073 -2089 | 110 | 74% | 6 |
5 | NAPOLI, N , STROLLO, R , PALADINI, A , BRIGANTI, SI , POZZILLI, P , EPSTEIN, S , (2014) THE ALLIANCE OF MESENCHYMAL STEM CELLS, BONE, AND DIABETES.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. VOL. . ISSUE . P. - | 166 | 52% | 2 |
6 | SHANBHOGUE, VV , MITCHELL, DM , ROSEN, CJ , BOUXSEIN, ML , (2016) TYPE 2 DIABETES AND THE SKELETON: NEW INSIGHTS INTO SWEET BONES.LANCET DIABETES & ENDOCRINOLOGY. VOL. 4. ISSUE 2. P. 159 -173 | 80 | 64% | 10 |
7 | RAKEL, A , SHEEHY, O , RAHME, E , LELORIER, J , (2008) OSTEOPOROSIS AMONG PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES.DIABETES & METABOLISM. VOL. 34. ISSUE 3. P. 193 -205 | 92 | 88% | 57 |
8 | ZHANG, YJ , BRADLEY, AD , WANG, D , REINHARDT, RA , (2014) STATINS, BONE METABOLISM AND TREATMENT OF BONE CATABOLIC DISEASES.PHARMACOLOGICAL RESEARCH. VOL. 88. ISSUE . P. 53 -61 | 86 | 81% | 11 |
9 | MOSHIRI, A , SHARIFI, AM , ORYAN, A , (2016) ROLE OF SIMVASTATIN ON FRACTURE HEALING AND OSTEOPOROSIS: A SYSTEMATIC REVIEW ON INVIVO INVESTIGATIONS.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 43. ISSUE 7. P. 659 -684 | 88 | 81% | 0 |
10 | VESTERGAARD, P , (2007) DISCREPANCIES IN BONE MINERAL DENSITY AND FRACTURE RISK IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES - A META-ANALYSIS.OSTEOPOROSIS INTERNATIONAL. VOL. 18. ISSUE 4. P. 427-444 | 60 | 81% | 465 |
Classes with closest relation at Level 2 |